Not Signed In -
Muscular dystrophy, Duchenne and Becker types |
DBMD; Duchenne/Becker muscular dystrophy |
Clinical Trial: A Safety Study in Adult Muscular Dystrophy Patients
This study is currently recruiting patients.
|
Purpose
The purpose of this phase I/II, multicenter, safety trial is to study MYO-029 in adult patients with muscular dystrophy.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Becker Muscular Dystrophy Facioscapulohumeral Muscular Dystrophy Limb-Girdle Muscular Dystrophy | Drug: MYO-029 | Phase I Phase II |
MedlinePlus related topics: Muscular Dystrophy
Genetics Home Reference related topics: muscular dystrophy, Duchenne and Becker types
Study Type: Interventional
Study Design: Treatment, Safety Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Written informed consent.
- Confirmed clinical and molecular diagnosis of Becker Muscular Dystrophy (BMD), Facioscapulohumeral Muscular Dystrophy (FSHD), or Limb-Girdle Muscular Dystrophy (LGMD).
- Independently ambulatory.
Exclusion Criteria:
- Patients with certain clinical conditions.
- Patients using steroids or other medications with the potential to affect muscle function.
- History of sensitivity to monoclonal antibodies or protein pharmaceuticals.
- Pregnant or lactating women.
Location and Contact Information
District of Columbia
Research Site, Washington, District of Columbia, 20010, United States; Recruiting
Research Coordinator 202-884-4110
Maryland
Research Site, Baltimore, Maryland, 21287-7519, United States; Recruiting
For Study Information Call: 866-879-7480
More Information
Study ID Numbers: 3147K2-101-WW
Record last reviewed: March 2005
Last Updated: March 14, 2005
Record first received: February 22, 2005
ClinicalTrials.gov Identifier: NCT00104078
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 14, 2005
Record first received: February 22, 2005
ClinicalTrials.gov Identifier: NCT00104078
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
